CNEU MEDICAL s.r.o.

CNEU MEDICAL s.r.o.

We have been developing and manufacturing the unique diagnostic

IVD medical device for self-testing for the early detection of possible

oncological disease.

Our unique tester CarciReagent has significant sensitivity for malignant

tumors (96,70 %) and specificity in healthy population (99,40 %).

CarciReagent is an IVD diagnostic medical test kit for self-testing for

proof of an indicative amount of monohydroxyphenols metabolites

(tyrosine) in the patient‘s urine.

Tyrosine can be used for the possible detection of malignant tumors

as stomach, esophageal, colon, pancreatic, rectal, liver, cervical and

breast cancer.

CNEU MEDICAL s.r.o.

Office: Národní 58/32, Nové Město, 110 0 Prague 1, Czech Republic